Research

Breaking Down Precision Medicine

UNC Lineberger designs, develops and delivers CAR-T therapy to to attack cancers.

UNC Lineberger designs, develops and delivers CAR-T therapy to to attack cancers.

The Lineberger Comprehensive Care Center at Carolina is revolutionizing cancer treatments in the Southeastern region of the United States.

UNC Lineberger is one of only a select few academic centers in the country with the scientific, technical and clinical abilities to treat cancers that fail to respond to standard treatments. The center is working todesign, develop and deliver chimeric antigen T-cell, or CAR-T therapies, to infuse into new tumor targets. Since these therapies are not commercially available, UNC Lineberger is making it possible for people who live in or near the Southeastern U.S. to stay closer to home to undergo clinical immunotherapy treatment for cancer.

Read the complete Carolina Story from UNC Lineberger…Opens in new window

UNC Lineberger Comprehensive Cancer Center Funding Priorities

    Readers Also Viewed...

    Tom, Wilson, and Nancy Chewning stand in their house.
    Donor

    Venture Philanthropy

    Investing in nascent research ideas may unlock future cures

    Dr. Lisa Carey wears a white lab coat and poses in a hospital hallway.
    Donor

    Supporting Innovative Cancer Treatments

    Donor gives $25 million to establish UNC Lineberger Center for Triple Negative Breast Cancer.

    Rich Preyer and Marilyn Jacobs Preyer
    Donor

    Reducing Breast Cancer Disparities And Barriers To Care

    Rich Preyer and Marilyn Jacobs Preyer have donated $1 million to support UNC Lineberger Comprehensive Cancer Center’s Carolina Breast Cancer Study

    Donor

    Grateful patient and husband establish breast cancer research fund

    Ensuring access to the most advanced care

    Health

    Deepening Our Understanding

    Using next generation sequencing to better understand COVID-19

    Health

    Precision Cancer Treatments

    "It's an exciting approach; we hit the tumor hard with little toxicity, leaving room for other therapy."